[ad_1] Medley Pharmaceuticals has called off its sale after talks with lead contender Cipla failed on a valuation mismatch and differences over some agreement terms, multiple people aware of the development said.This is the second pharma merger and acquisition (M&A) transaction that has been called off or postponed recently due...
Why India’s growth will slowdown in the next two years, Legal News, ET LegalWorld – Legal Firms
[ad_1] NEW DELHI: India's growth is likely to slow in the next two years as global slowdown has already begun to impact India's exports and industrial activity.According to an analysis by Crisil Ratings, India's GDP growth will slow to 7% in fiscal 2023 and 6 percent in fiscal 2024 as...